Johnson & Johnson Invests $1B+ in U.S. Vision Manufacturing

Johnson & Johnson announced an investment of over $1 billion in Jacksonville, Fla. to bolster its Vision operations by scaling U.S. manufacturing, packaging, and distribution capabilities.

The investment includes construction of a new distribution facility, along with advanced manufacturing and packaging technologies to expand capacity and meet rising demand for the company’s AcuVue-brand contact lenses. Construction of the new facility has begun and has the goal of becoming fully operational in 2028.

“This investment reinforces our long-standing conviction that advanced manufacturing in the United States is essential to delivering innovative, high quality healthcare solutions to patients at home and around the world,” said Joaquin Duato, chairman and CEO of Johnson & Johnson. “By further strengthening our Vision operations in Jacksonville with next-generation manufacturing, packaging and distribution capabilities, we are enhancing the resilience of our U.S. supply chain while helping more people see better and live better. This commitment reflects the confidence we have in our people, our technology, and our more than 40-year legacy of advancing eye health globally.”

This announcement is part of J&J’s previously announced $55 billion U.S. investment in manufacturing, R&D, and technology through early 2029. It builds on the company’s $6 billion annual economic impact in Florida and supports continued growth of its Jacksonville operations, strengthening opportunities for the 3,500 employees based in the area.

“Johnson & Johnson’s commitment is a strong vote of confidence in Jacksonville, our workforce, and our future,” said Mayor Donna Deegan. “Jacksonville continues to lead in advanced manufacturing and life sciences innovation. This expansion strengthens our high-tech footprint while creating quality jobs and long-term opportunities for our community.”

Comments from government sources

U.S. Senator Rick Scott: “Florida continues to play a leading role in strengthening America’s healthcare supply chain to better serve patients. The billion-dollar investment in Jacksonville will help expand the domestic capacity and strengthen America’s healthcare infrastructure. That means more jobs in Florida, a stronger national economy, less reliance on foreign healthcare products, and better results for our nation’s long-term health and competitiveness.”

U.S. Senator Ashley Moody: “I am thrilled to see this major $1 billion investment in our state, funding new state of the art facilities and supporting jobs in the Jacksonville area. This is more than simple investment—this represents a down payment on the future of Jacksonville and the state of Florida. Companies are moving to Florida in droves, and massive investment such as this highlights Florida as the nation’s top state to grow your family and your business.”

Representative John Rutherford: “Johnson & Johnson’s continued investment in Jacksonville reflects the region’s strength in advanced manufacturing and critical healthcare production. It supports a skilled workforce, strengthens domestic capacity, and reinforces Northeast Florida’s role in keeping America economically competitive.”

Representative Aaron Bean: “Johnson & Johnson’s $1 billion investment in Jacksonville will strengthen the supply chain for critical vision products while creating high-quality jobs and generating significant economic benefits for Northeast Florida. The project reinforces Jacksonville’s status as a premier destination for healthcare manufacturing and innovation, helping ensure the region remains at the forefront of supporting patients and advancing medical technology.”